Martin A. Philbert, Dean and Professor of Toxicology of the University of Michigan School of Public Health, has been elected to the Institute of Medicine. This award is considered to be one of the most prestigious in the health and medical fields and is presented to those health leaders who have demonsrated outstanding professional achievement and commitment to service. Dr. Philbert has worked much of his professional career to inform policymakers and key decisionmakers in government agencies about topical scientific issues and the science of toxicology in general.
A neurotoxicologist, Dr. Philbert is internationally recognized for his expertise in neurotoxicology and experimental neuropathology. He maintains a continuously federally funded portfolio of basic research activities, focusing on the development of flexible polymer nanoplatforms for the optical sensing of ions and small molecules and the early detection and treatment of brain tumors. Additional research includes the mitochondrial mechanisms of chemically induced neuropathic states.
Dr. Philbert is a national advisor and consultant, widely respected for his expertise in neurotoxicology and experimental neuropathology. He chairs the US Food and Drug Administration (US FDA) Science Board, and chaired the US FDA Science Board Subcommittee on Bisphenol A. He also has served on the National Advisory Environmental Health Council of the National Institute of Environmental Health Sciences and provides consultation to federal agencies on a variety of issues surrounding emerging nanotechnologies. He is a standing member of the US FDA Science Advisory Board and served as chair and standing member of the US Environmental Protection Agency’s Board of Scientific Counselors. Among his publications in
Toxicological Sciences, Dr. Philbert was an invited contributor to the 50th Anniversary Supplement of this official journal of SOT, co-authoring with Andrew B. Maynard and David B. Warheit, "
The New Toxicology of Sophisticated Materials: Nanotoxicology and Beyond."